Loading market dashboard
Adverum Biotechnologies, Inc.
ADVMHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Adverum Biotechnologies, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $16.70M | $16.70M - $16.70M | -$3.34M | -$3.618 | 2 |
| Dec 2028 | $7.38M | $7.38M - $7.38M | -$1.47M | -$4.266 | 1 |
| Dec 2027 | $52.50M | $52.50M - $52.50M | -$10.50M | -$4.493 | 3 |
| Dec 2026 | $15.20M | $15.20M - $15.20M | -$3.04M | -$4.828 | 4 |
| Dec 2025 | $200.0K | $200.0K - $200.0K | -$40.0K | -$8.04 | 4 |
| Dec 2024 | $1.00M | $1.00M - $1.00M | -$200.0K | -$4.998 | 6 |
| Dec 2023 | $3.60M | $3.53M - $3.92M | -$720.0K | -$12.622 | 6 |
| Dec 2021 | $7.67M | $7.67M - $7.67M | -$1.53M | -$14.80 | 3 |
| Dec 2019 | $480.0K | $480.0K - $480.0K | -$96.0K | -$10.10 | 2 |
| Dec 2018 | $1.99M | $1.99M - $1.99M | -$397.4K | -$12.02 | 3 |
| Dec 2017 | $1.70M | $1.70M - $1.70M | -$339.4K | -$12.925 | 3 |
| Dec 2016 | $900.0K | $900.0K - $900.0K | -$180.0K | -$24.20 | 2 |